Literature DB >> 31797490

Post-discharge haemodilution, congestion, and clinical outcomes among patients hospitalized for heart failure with reduced ejection fraction: results from the EVEREST trial.

Ankeet S Bhatt1, Muthiah Vaduganathan1, Ravi B Patel2, Gregg C Fonarow3, Haris P Subacius4, Marvin A Konstam5, Faiez Zannad6, Javed Butler7, Stephen J Greene8,9.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31797490      PMCID： PMC6995413          DOI： 10.1002/ejhf.1651

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN： 1388-9842            Impact factor:   15.534


× No keyword cloud information.
  9 in total

Review 1.  The vulnerable phase after hospitalization for heart failure.

Authors:  Stephen J Greene; Gregg C Fonarow; Muthiah Vaduganathan; Sadiya S Khan; Javed Butler; Mihai Gheorghiade
Journal:  Nat Rev Cardiol       Date:  2015-02-10       Impact factor: 32.419

2.  Effect of Patient-Centered Transitional Care Services on Clinical Outcomes in Patients Hospitalized for Heart Failure: The PACT-HF Randomized Clinical Trial.

Authors:  Harriette G C Van Spall; Shun Fu Lee; Feng Xie; Urun Erbas Oz; Richard Perez; Peter R Mitoff; Manish Maingi; Michael C Tjandrawidjaja; Michael Heffernan; Mohammad I Zia; Liane Porepa; Mohamed Panju; Lehana Thabane; Ian D Graham; R Brian Haynes; Dilys Haughton; Kim D Simek; Dennis T Ko; Stuart J Connolly
Journal:  JAMA       Date:  2019-02-26       Impact factor: 56.272

Review 3.  Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine.

Authors:  Mihai Gheorghiade; Ferenc Follath; Piotr Ponikowski; Jeffrey H Barsuk; John E A Blair; John G Cleland; Kenneth Dickstein; Mark H Drazner; Gregg C Fonarow; Tiny Jaarsma; Guillaume Jondeau; Jose Lopez Sendon; Alexander Mebazaa; Marco Metra; Markku Nieminen; Peter S Pang; Petar Seferovic; Lynne W Stevenson; Dirk J van Veldhuisen; Faiez Zannad; Stefan D Anker; Andrew Rhodes; John J V McMurray; Gerasimos Filippatos
Journal:  Eur J Heart Fail       Date:  2010-03-30       Impact factor: 15.534

4.  Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the Efficacy of Vasopressin antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST).

Authors:  Mihai Gheorghiade; Cesare Orlandi; John C Burnett; David Demets; Liliana Grinfeld; Aldo Maggioni; Karl Swedberg; James E Udelson; Faiez Zannad; Christopher Zimmer; Marvin A Konstam
Journal:  J Card Fail       Date:  2005-05       Impact factor: 5.712

5.  Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial.

Authors:  Marvin A Konstam; Mihai Gheorghiade; John C Burnett; Liliana Grinfeld; Aldo P Maggioni; Karl Swedberg; James E Udelson; Faiez Zannad; Thomas Cook; John Ouyang; Christopher Zimmer; Cesare Orlandi
Journal:  JAMA       Date:  2007-03-25       Impact factor: 56.272

6.  Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival.

Authors:  Jeffrey M Testani; Jennifer Chen; Brian D McCauley; Stephen E Kimmel; Richard P Shannon
Journal:  Circulation       Date:  2010-07-06       Impact factor: 29.690

Review 7.  The use of diuretics in heart failure with congestion - a position statement from the Heart Failure Association of the European Society of Cardiology.

Authors:  Wilfried Mullens; Kevin Damman; Veli-Pekka Harjola; Alexandre Mebazaa; Hans-Peter Brunner-La Rocca; Pieter Martens; Jeffrey M Testani; W H Wilson Tang; Francesco Orso; Patrick Rossignol; Marco Metra; Gerasimos Filippatos; Petar M Seferovic; Frank Ruschitzka; Andrew J Coats
Journal:  Eur J Heart Fail       Date:  2019-01-01       Impact factor: 15.534

8.  Impact of haemoconcentration during acute heart failure therapy on mortality and its relationship with worsening renal function.

Authors:  Tobias Breidthardt; Zoraida Moreno Weidmann; Raphael Twerenbold; Claudine Gantenbein; Fabio Stallone; Katharina Rentsch; Maria Rubini Gimenez; Nikola Kozhuharov; Zaid Sabti; Dominik Breitenbücher; Karin Wildi; Christian Puelacher; Ursina Honegger; Max Wagener; Carmela Schumacher; Petra Hillinger; Stefan Osswald; Christian Mueller
Journal:  Eur J Heart Fail       Date:  2016-10-19       Impact factor: 15.534

9.  Haemoconcentration, renal function, and post-discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial.

Authors:  Stephen J Greene; Mihai Gheorghiade; Muthiah Vaduganathan; Andrew P Ambrosy; Robert J Mentz; Haris Subacius; Aldo P Maggioni; Savina Nodari; Marvin A Konstam; Javed Butler; Gerasimos Filippatos
Journal:  Eur J Heart Fail       Date:  2013-07-11       Impact factor: 15.534
  9 in total
  1 in total

Review 1.  The role of vitamin D in cardiovascular disease and COVID-19.

Authors:  Elissa Driggin; Mahesh V Madhavan; Aakriti Gupta
Journal:  Rev Endocr Metab Disord       Date:  2022-03-02       Impact factor: 9.306
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.